100XBIO develops single-cell and spatial biology technologies enabling high-resolution cellular analysis for research and drug discovery.
100XBIO has raised $110K in total funding. The most recent round was Pre-Seed. The last funding was announced in October 2026.
100XBIO is headquartered in Woburn, United States.
100XBIO develops single-cell and spatial biology technologies enabling high-resolution cellular analysis for research and drug discovery.
100XBIO is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"100XBIO — Funding & Investors." VCBacked, October 21, 2026, https://www.vcbacked.co/company/100xbio. Accessed November 13, 2026.
VCBacked. (2026). 100XBIO — Funding & Investors. Retrieved November 13, 2026, from https://www.vcbacked.co/company/100xbio
{{cite web |title=100XBIO — Funding & Investors |url=https://www.vcbacked.co/company/100xbio |website=VCBacked |access-date=November 13, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at 100XBIO? Request a listing update